Replies to post #113385 on Bioelectronics Corp (BIEL)

[JustGoDeep]

AGAIN Market-Cap <$12-Million NOT Outstanding-Shares

is how a company is valued,

and Of COURSE management doesn't care or want to turn a profit nor do they want to get rich and be rewarded for the fruits of their labor,

Umm, I call BS.

[srinsocal]

The 18 billion shares have funded the company for the last 17 years and resulted in FDA OTC Clearance for ActiPatch. Compare that to what Big Pharma spends to get a device or drug through the FDA process.

The .0006 share price is a bargain, better add to your position before the many positive events that are in the pipeline start flowing.

You must have missed it. BIEL issued a detailed letter on 8/22/2017 explaining the company status and path forward.

Those who are aware of the advantages of using the ActiPatch instead of drugs for pain relief have been able to purchase it in the US through the largest Online retailer in the world, Amazon, for the last 6 months.

Being available on US retail shelves will not help sales much unless there is an accompanying marketing campaign to educate consumers on the advantages of using the ActiPatch for pain relief.

* effective pain relief that can be used 24/7
* no risk of addiction
* zero side effects
* ActiPatch promotes healing damaged cells while it relieves pain
* Pain relief for 4 cents an hour
* no fear of interactions with other medications
* no tingling sensations that occur with pain blocking devices like TENS